あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/12/23 | 2,039 | 2,065 | 2,024 | 2,064 | +41 | +2% | 56,700 |
| 2025/12/22 | 2,037 | 2,037 | 2,013 | 2,023 | -15 | -0.7% | 44,100 |
| 2025/12/19 | 2,073 | 2,078 | 2,029 | 2,038 | -3 | -0.1% | 67,900 |
| 2025/12/18 | 2,011 | 2,047 | 2,011 | 2,041 | +31 | +1.5% | 66,600 |
| 2025/12/17 | 1,998 | 2,011 | 1,983 | 2,010 | +23 | +1.2% | 48,600 |
| 2025/12/16 | 1,963 | 1,998 | 1,963 | 1,987 | +27 | +1.4% | 49,500 |
| 2025/12/15 | 1,930 | 1,961 | 1,920 | 1,960 | +30 | +1.6% | 54,700 |
| 2025/12/12 | 1,984 | 1,984 | 1,922 | 1,930 | -15 | -0.8% | 74,700 |
| 2025/12/11 | 1,980 | 1,990 | 1,944 | 1,945 | -31 | -1.6% | 49,300 |
| 2025/12/10 | 1,960 | 1,987 | 1,960 | 1,976 | +16 | +0.8% | 49,500 |
| 2025/12/09 | 1,966 | 1,981 | 1,958 | 1,960 | -6 | -0.3% | 77,300 |
| 2025/12/08 | 1,965 | 1,971 | 1,949 | 1,966 | +37 | +1.9% | 60,800 |
| 2025/12/05 | 1,960 | 1,965 | 1,927 | 1,929 | -37 | -1.9% | 44,800 |
| 2025/12/04 | 1,951 | 1,969 | 1,940 | 1,966 | +16 | +0.8% | 38,600 |
| 2025/12/03 | 1,998 | 1,998 | 1,950 | 1,950 | -53 | -2.6% | 55,700 |
| 2025/12/02 | 2,030 | 2,030 | 1,997 | 2,003 | -27 | -1.3% | 36,900 |
| 2025/12/01 | 2,055 | 2,060 | 2,030 | 2,030 | -25 | -1.2% | 28,000 |
| 2025/11/28 | 2,035 | 2,069 | 2,035 | 2,055 | +14 | +0.7% | 58,000 |
| 2025/11/27 | 2,064 | 2,066 | 2,033 | 2,041 | -23 | -1.1% | 43,300 |
| 2025/11/26 | 2,058 | 2,080 | 2,058 | 2,064 | +13 | +0.6% | 32,800 |
| 2025/11/25 | 2,081 | 2,081 | 2,049 | 2,051 | -13 | -0.6% | 28,700 |
| 2025/11/21 | 2,033 | 2,064 | 2,033 | 2,064 | +32 | +1.6% | 44,800 |
| 2025/11/20 | 2,049 | 2,050 | 2,028 | 2,032 | +9 | +0.4% | 42,000 |
| 2025/11/19 | 2,021 | 2,034 | 2,011 | 2,023 | +2 | +0.1% | 47,100 |
| 2025/11/18 | 2,027 | 2,038 | 2,021 | 2,021 | -12 | -0.6% | 41,300 |
| 2025/11/17 | 2,044 | 2,046 | 2,025 | 2,033 | -11 | -0.5% | 29,800 |
| 2025/11/14 | 2,050 | 2,060 | 2,040 | 2,044 | -2 | -0.1% | 34,000 |
| 2025/11/13 | 2,065 | 2,075 | 2,039 | 2,046 | +2 | +0.1% | 25,000 |
| 2025/11/12 | 2,050 | 2,068 | 2,035 | 2,044 | +11 | +0.5% | 45,400 |
| 2025/11/11 | 2,050 | 2,052 | 2,021 | 2,033 | -23 | -1.1% | 45,400 |
| 2025/11/10 | 2,059 | 2,059 | 2,034 | 2,056 | +14 | +0.7% | 30,600 |
| 2025/11/07 | 2,050 | 2,057 | 2,033 | 2,042 | ±0 | ±0% | 51,000 |
| 2025/11/06 | 2,007 | 2,047 | 1,990 | 2,042 | +65 | +3.3% | 176,400 |
| 2025/11/05 | 2,000 | 2,042 | 1,963 | 1,977 | -137 | -6.5% | 176,400 |
| 2025/11/04 | 2,099 | 2,126 | 2,078 | 2,114 | +20 | +1% | 72,200 |
| 2025/10/31 | 2,076 | 2,099 | 2,071 | 2,094 | +18 | +0.9% | 38,200 |
| 2025/10/30 | 2,111 | 2,111 | 2,064 | 2,076 | +15 | +0.7% | 210,900 |
| 2025/10/29 | 2,124 | 2,127 | 2,058 | 2,061 | -63 | -3% | 61,700 |
| 2025/10/28 | 2,178 | 2,178 | 2,120 | 2,124 | -64 | -2.9% | 75,500 |
| 2025/10/27 | 2,180 | 2,194 | 2,170 | 2,188 | +22 | +1% | 26,500 |
| 2025/10/24 | 2,204 | 2,204 | 2,157 | 2,166 | -19 | -0.9% | 36,800 |
| 2025/10/23 | 2,210 | 2,218 | 2,182 | 2,185 | -14 | -0.6% | 38,200 |
| 2025/10/22 | 2,206 | 2,212 | 2,188 | 2,199 | -10 | -0.5% | 39,000 |
| 2025/10/21 | 2,200 | 2,230 | 2,179 | 2,209 | +80 | +3.8% | 134,900 |
| 2025/10/20 | 2,154 | 2,174 | 2,112 | 2,129 | +14 | +0.7% | 110,300 |
| 2025/10/17 | 2,108 | 2,127 | 2,105 | 2,115 | +7 | +0.3% | 20,200 |
| 2025/10/16 | 2,117 | 2,135 | 2,108 | 2,108 | -9 | -0.4% | 25,900 |
| 2025/10/15 | 2,105 | 2,134 | 2,092 | 2,117 | +34 | +1.6% | 34,200 |
| 2025/10/14 | 2,102 | 2,125 | 2,065 | 2,083 | -62 | -2.9% | 58,800 |
| 2025/10/10 | 2,162 | 2,177 | 2,144 | 2,145 | -49 | -2.2% | 50,600 |
151~
200
件表示中 / 1308件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかHD | 201,100円 | +2.6% | +7.7% | 3.23% | 11.90倍 | 0.81倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
| 杏林製薬 | 107,400円 | -3.5% | -42.9% | 2.33% | 41.13倍 | 0.43倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| JCRファーマ | 49,300円 | +13.4% | -57.1% | 4.06% | 300.61倍 | 1.29倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| タウンズ | 46,800円 | -19.2% | -49.8% | 5.98% | 8.76倍 | 2.87倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| 富士製薬 | 187,000円 | +14.7% | +31.9% | 2.62% | 21.81倍 | 0.95倍 |
|
女性医療に強い。後発薬から新薬へシフト中。バイオ後続品に注力。子会社通じ海外展開も |
市場注目の銘柄
チャート関連のコラム